Loading... Please wait!

Abattis Unveils “Comfort”, Its Proprietary New Chronic Pain and Inflammation Product to Start Shipping November 2018

September 24, 2018 0Middle East Logistics News

VANCOUVER, British Columbia, Sept. 24, 2018 (GLOBE NEWSWIRE) — Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce the pending release of “Comfort”, a nutraceutical designed to target chronic pain and …
Abattis Unveils “Comfort”, Its Proprietary New Chronic Pain and Inflammation Product to Start Shipping November 2018


Leave a Reply

Your email address will not be published. Required fields are marked *

QUICK LINKS